These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

634 related items for PubMed ID: 20629054

  • 1. Targeted metabolomics for biomarker discovery.
    Griffiths WJ, Koal T, Wang Y, Kohl M, Enot DP, Deigner HP.
    Angew Chem Int Ed Engl; 2010 Jul 26; 49(32):5426-45. PubMed ID: 20629054
    [Abstract] [Full Text] [Related]

  • 2. Analytical strategies in lipidomics and applications in disease biomarker discovery.
    Hu C, van der Heijden R, Wang M, van der Greef J, Hankemeier T, Xu G.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Sep 15; 877(26):2836-46. PubMed ID: 19233743
    [Abstract] [Full Text] [Related]

  • 3. Knowledge discovery in metabolomics: an overview of MS data handling.
    Boccard J, Veuthey JL, Rudaz S.
    J Sep Sci; 2010 Feb 15; 33(3):290-304. PubMed ID: 20087872
    [Abstract] [Full Text] [Related]

  • 4. Mass spectrometry: from proteomics to metabolomics and lipidomics.
    Griffiths WJ, Wang Y.
    Chem Soc Rev; 2009 Jul 15; 38(7):1882-96. PubMed ID: 19551169
    [Abstract] [Full Text] [Related]

  • 5. Applications of liquid chromatography coupled to mass spectrometry-based metabolomics in clinical chemistry and toxicology: A review.
    Roux A, Lison D, Junot C, Heilier JF.
    Clin Biochem; 2011 Jan 15; 44(1):119-35. PubMed ID: 20800591
    [Abstract] [Full Text] [Related]

  • 6. [Recent advances in metabonomics].
    Xu GW, Lu X, Yang SL.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2007 Dec 15; 29(6):701-11. PubMed ID: 18595244
    [Abstract] [Full Text] [Related]

  • 7. Stability-based biomarker selection.
    Wehrens R, Franceschi P, Vrhovsek U, Mattivi F.
    Anal Chim Acta; 2011 Oct 31; 705(1-2):15-23. PubMed ID: 21962342
    [Abstract] [Full Text] [Related]

  • 8. Targeted proteomics by selected reaction monitoring mass spectrometry: applications to systems biology and biomarker discovery.
    Elschenbroich S, Kislinger T.
    Mol Biosyst; 2011 Feb 31; 7(2):292-303. PubMed ID: 20976349
    [Abstract] [Full Text] [Related]

  • 9. Challenges and developments in tandem mass spectrometry based clinical metabolomics.
    Ceglarek U, Leichtle A, Brügel M, Kortz L, Brauer R, Bresler K, Thiery J, Fiedler GM.
    Mol Cell Endocrinol; 2009 Mar 25; 301(1-2):266-71. PubMed ID: 19007853
    [Abstract] [Full Text] [Related]

  • 10. NMR and pattern recognition methods in metabolomics: from data acquisition to biomarker discovery: a review.
    Smolinska A, Blanchet L, Buydens LM, Wijmenga SS.
    Anal Chim Acta; 2012 Oct 31; 750():82-97. PubMed ID: 23062430
    [Abstract] [Full Text] [Related]

  • 11. Bioinformatics for mass spectrometry-based metabolomics.
    Enot DP, Haas B, Weinberger KM.
    Methods Mol Biol; 2011 Oct 31; 719():351-75. PubMed ID: 21370092
    [Abstract] [Full Text] [Related]

  • 12. Mass spectrometry-based technologies for high-throughput metabolomics.
    Han J, Datla R, Chan S, Borchers CH.
    Bioanalysis; 2009 Dec 31; 1(9):1665-84. PubMed ID: 21083110
    [Abstract] [Full Text] [Related]

  • 13. Metabolomics: towards understanding traditional Chinese medicine.
    Zhang A, Sun H, Wang Z, Sun W, Wang P, Wang X.
    Planta Med; 2010 Dec 31; 76(17):2026-35. PubMed ID: 21058239
    [Abstract] [Full Text] [Related]

  • 14. Practical analytical approach for the identification of biomarker candidates in prediabetic state based upon metabonomic study by ultraperformance liquid chromatography coupled to electrospray ionization time-of-flight mass spectrometry.
    Tsutsui H, Maeda T, Toyo'oka T, Min JZ, Inagaki S, Higashi T, Kagawa Y.
    J Proteome Res; 2010 Aug 06; 9(8):3912-22. PubMed ID: 20557141
    [Abstract] [Full Text] [Related]

  • 15. The expanding role of mass spectrometry in metabolite profiling and characterization.
    Want EJ, Cravatt BF, Siuzdak G.
    Chembiochem; 2005 Nov 06; 6(11):1941-51. PubMed ID: 16206229
    [Abstract] [Full Text] [Related]

  • 16. Current practice of liquid chromatography-mass spectrometry in metabolomics and metabonomics.
    Gika HG, Theodoridis GA, Plumb RS, Wilson ID.
    J Pharm Biomed Anal; 2014 Jan 06; 87():12-25. PubMed ID: 23916607
    [Abstract] [Full Text] [Related]

  • 17. Data processing pipelines for comprehensive profiling of proteomics samples by label-free LC-MS for biomarker discovery.
    Christin C, Bischoff R, Horvatovich P.
    Talanta; 2011 Jan 30; 83(4):1209-24. PubMed ID: 21215856
    [Abstract] [Full Text] [Related]

  • 18. MS-based plant metabolomic approaches for biomarker discovery.
    Wolfender JL, Glauser G, Boccard J, Rudaz S.
    Nat Prod Commun; 2009 Oct 30; 4(10):1417-30. PubMed ID: 19911581
    [Abstract] [Full Text] [Related]

  • 19. Recent advances of chromatography and mass spectrometry in lipidomics.
    Li M, Zhou Z, Nie H, Bai Y, Liu H.
    Anal Bioanal Chem; 2011 Jan 30; 399(1):243-9. PubMed ID: 21052649
    [Abstract] [Full Text] [Related]

  • 20. From exogenous to endogenous: the inevitable imprint of mass spectrometry in metabolomics.
    Want EJ, Nordström A, Morita H, Siuzdak G.
    J Proteome Res; 2007 Feb 30; 6(2):459-68. PubMed ID: 17269703
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.